Cargando…
Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib
A 71-year-old woman with a four-year history of chronic lymphocytic leukemia (CLL) received ibrutinib as initial treatment due to progressive anemia and thrombocytopenia. Eleven months after the start of the treatments, although her cytopenia had ameliorated, she developed classic Hodgkin lymphoma,...
Autores principales: | Koshiishi, Megumi, Odate, Toru, Nakagawa, Yukie, Suzuki, Jun, Kumagai, Takuya, Kawashima, Ichiro, Yamamoto, Takeo, Nakajima, Kei, Tanaka, Masaru, Oishi, Naoki, Kondo, Tetuso, Kirito, Keita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580765/ https://www.ncbi.nlm.nih.gov/pubmed/33896865 http://dx.doi.org/10.2169/internalmedicine.6979-20 |
Ejemplares similares
-
Combined Coagulopathy Can Induce Both Hemorrhagic and Thrombotic Complications in Multiple Myeloma
por: Kawashima, Ichiro, et al.
Publicado: (2018) -
Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis
por: Koshiishi, Megumi, et al.
Publicado: (2017) -
Bone Marrow Invasion of Small Cell Neuroendocrine Carcinoma of the Endometrium: A Diagnostic Pitfall Mimicking a Haematological Malignancy
por: Kawashima, Ichiro, et al.
Publicado: (2019) -
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma
por: Hanel, Walter, et al.
Publicado: (2023) -
A Very Rare Case of Hypereosinophilic Syndrome Secondary to Natural Killer/T-Cell Lymphoma
por: Yamamoto, Takanori, et al.
Publicado: (2018)